Critical Reviews on Pediatric Dosage Form Developments and Medical Devices

Gurkirat Kaur1, Dheeraj Nagpal1, Kalpana Nagpal1

  • 1Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, U.P., India.

Insights

Pediatric drug dosing requires specialized approaches beyond adult standards. Novel formulations and medical devices like oral pens and Medibottles improve pediatric medication administration, reducing errors and toxicity.

Area of Science:

  • Pediatric Pharmacology
  • Drug Delivery Systems
  • Biopharmaceutical Sciences

Background:

  • Pediatric patients are not simply
  • miniature adults
  • due to distinct physiological differences affecting drug pharmacokinetics and pharmacodynamics.
  • Current pediatric dosing practices, often based on age, weight, or reduced adult doses, are frequently inadequate.
  • Organ development and body composition variations in children necessitate tailored pharmaceutical strategies.

Purpose of the Study:

  • To review the challenges in designing pediatric dosage forms.
  • To highlight advancements in medical devices for pediatric drug administration.
  • To emphasize the need for customized solutions to improve medication safety and efficacy in children.

Main Methods:

  • Literature review of pediatric drug formulation and delivery systems.
  • Analysis of novel medical devices designed for pediatric use.
  • Synthesis of information on challenges and innovations in pediatric pharmacotherapy.

Main Results:

  • Customized formulations like mini-tablets and oro-dispersible films address administration difficulties.
  • Innovative medical devices, including oral solid dosage pens, Nipple Shield Delivery Systems (NSDS), and Medibottles, facilitate accurate dosing.
  • These advancements offer flexibility and convenience, overcoming barriers to effective drug delivery in pediatric patients.

Conclusions:

  • Specialized dosage forms and medical devices are crucial for safe and effective pediatric drug administration.
  • Addressing unique pediatric physiological parameters is essential for optimizing therapeutic outcomes.
  • Innovations in drug delivery systems can significantly reduce medication errors, incomplete absorption, and toxicity in children.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
126
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
131